Pradimicin Q, a new pradimicin aglycone, with alpha-glucosidase inhibitory activity.
Sawada
Y
Y
Bristol-Myers Squibb Research Institute, Tokyo, Japan.
Tsuno
T
T
Ueki
T
T
Yamamoto
H
H
Fukagawa
Y
Y
Oki
T
T
D000191:Actinomycetaceae / Q000737:chemistry*; D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology*; D000935:Antifungal Agents / Q000737:chemistry / Q000302:isolation & purification / Q000494:pharmacology*; D065089:Glycoside Hydrolase Inhibitors; D008826:Microbial Sensitivity Tests; D013329:Structure-Activity Relationship; D000095643:Pradimicins and Benanomicins
D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic; D000935:Antifungal Agents; D065089:Glycoside Hydrolase Inhibitors; C080897:pradimicin Q; D000095643:Pradimicins and Benanomicins